Nuwellis Inc (NUWE)

$3.89 +0.04 (1.04%)
Market Cap 6.25M
Revenue (ttm) 8.74M
Net Income (ttm) -11.17M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -127.80%
Debt to Equity Ratio 0.00
Volume 359,100
Avg Vol 2,583,402
Day's Range N/A - N/A
Shares Out 1.66M
Stochastic %K 66%
Beta -0.19
Analysts Hold
Price Target $11.00

Company Profile

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and...

Industry: Medical Devices
Sector: Healthcare
Phone: 952 345 4200
Address:
12988 Valley View Road, Eden Prairie, United States
bazooka007
bazooka007 Feb. 4 at 8:26 AM
$NUWE hey NUWE show us a little good pr. Come on.
0 · Reply
rangervs
rangervs Feb. 4 at 12:39 AM
$BKYI nice movement still adding on the dips $NUWE same $GLSI
0 · Reply
Nuckle_Head
Nuckle_Head Feb. 3 at 2:53 PM
$NUWE looked like a double bottom on the chart. 📈 Cheers 🥂
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 3 at 1:44 PM
$NUWE RSI: 72.15, MACD: 0.4279 Vol: 0.85, MA20: 2.49, MA50: 2.34 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
nerowinger
nerowinger Feb. 2 at 9:15 PM
$NUWE split, dilution and repeat. Over years same story. Many patents and never cash…
1 · Reply
bazooka007
bazooka007 Feb. 2 at 7:35 PM
$NUWE finsih above 4 would be nice, finish above 4,15/4,20 would be super nice
0 · Reply
yaycapitalism
yaycapitalism Feb. 2 at 7:28 PM
$NUWE In.
0 · Reply
rangervs
rangervs Feb. 2 at 6:09 PM
$PBM c how this pans out power hour $NUWE still has some fuel ! $BKYI $1+ send it
0 · Reply
tonyzig
tonyzig Feb. 2 at 5:12 PM
$NUWE CTb shot to 560% this am and currently 428%. Looking squeezy…
0 · Reply
boredandstroked
boredandstroked Feb. 2 at 3:44 PM
$NUWE let's blow past 4.20 today.
0 · Reply
Latest News on NUWE
Nuwellis Appoints Carisa Schultz as Chief Financial Officer

Jan 30, 2026, 8:00 AM EST - 4 days ago

Nuwellis Appoints Carisa Schultz as Chief Financial Officer

Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market

Jan 29, 2026, 4:36 PM EST - 5 days ago

Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market

Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy

Jan 29, 2026, 4:35 PM EST - 5 days ago

Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy

Nuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare

Jan 27, 2026, 11:14 AM EST - 7 days ago

Nuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare

Nuwellis Announces Changes to Board of Directors

Jan 23, 2026, 4:40 PM EST - 11 days ago

Nuwellis Announces Changes to Board of Directors

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

Jan 6, 2026, 8:15 AM EST - 4 weeks ago

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

Dec 9, 2025, 8:15 AM EST - 2 months ago

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

Dec 4, 2025, 8:15 AM EST - 2 months ago

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

Nuwellis, Inc. (NUWE) Q3 2025 Earnings Call Prepared Remarks Transcript

Nov 12, 2025, 10:11 AM EST - 2 months ago

Nuwellis, Inc. (NUWE) Q3 2025 Earnings Call Prepared Remarks Transcript

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

Nov 12, 2025, 8:15 AM EST - 2 months ago

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology

Nov 10, 2025, 9:00 AM EST - 3 months ago

Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Oct 23, 2025, 9:00 AM EDT - 3 months ago

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Sep 30, 2025, 8:45 AM EDT - 4 months ago

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Sep 18, 2025, 9:00 AM EDT - 4 months ago

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Sep 17, 2025, 10:16 AM EDT - 4 months ago

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Sep 9, 2025, 9:00 AM EDT - 5 months ago

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Sep 4, 2025, 8:15 AM EDT - 5 months ago

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Aug 21, 2025, 8:15 AM EDT - 5 months ago

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Aug 19, 2025, 8:15 AM EDT - 6 months ago

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Aug 15, 2025, 8:15 AM EDT - 6 months ago

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 2:37 PM EDT - 6 months ago

Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 14, 2025, 8:15 AM EDT - 6 months ago

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Aug 7, 2025, 8:15 AM EDT - 6 months ago

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Aug 6, 2025, 8:15 AM EDT - 6 months ago

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Aug 5, 2025, 8:15 AM EDT - 6 months ago

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Nuwellis Stockholders Approve All Proposals at Special Meeting

Aug 4, 2025, 5:24 PM EDT - 6 months ago

Nuwellis Stockholders Approve All Proposals at Special Meeting

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Jul 23, 2025, 8:45 AM EDT - 6 months ago

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Jul 23, 2025, 8:15 AM EDT - 7 months ago

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Jul 22, 2025, 8:15 AM EDT - 7 months ago

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Jul 17, 2025, 7:35 AM EDT - 7 months ago

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Jul 15, 2025, 4:05 PM EDT - 7 months ago

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Nuwellis Appoints John Erb as Chief Executive Officer

Jul 2, 2025, 8:15 AM EDT - 7 months ago

Nuwellis Appoints John Erb as Chief Executive Officer

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Jun 10, 2025, 4:15 PM EDT - 8 months ago

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

Jun 9, 2025, 9:15 AM EDT - 8 months ago

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

May 13, 2025, 10:50 AM EDT - 9 months ago

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

May 13, 2025, 7:00 AM EDT - 9 months ago

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

May 12, 2025, 7:00 AM EDT - 9 months ago

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

May 8, 2025, 7:00 AM EDT - 9 months ago

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

Apr 24, 2025, 7:00 AM EDT - 10 months ago

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

Apr 22, 2025, 4:05 PM EDT - 10 months ago

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 12:23 PM EDT - 11 months ago

Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

Mar 11, 2025, 8:00 AM EDT - 11 months ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

Feb 24, 2025, 4:05 PM EST - 1 year ago

Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

Feb 20, 2025, 8:00 AM EST - 1 year ago

JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Feb 18, 2025, 4:15 PM EST - 1 year ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 11:02 AM EST - 1 year ago

Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

Nov 11, 2024, 8:00 AM EST - 1 year ago

Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nov 5, 2024, 9:28 AM EST - 1 year ago

Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Nov 4, 2024, 8:30 AM EST - 1 year ago

Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid

Nuwellis Announces Preliminary Results for Third Quarter of 2024

Nov 1, 2024, 4:15 PM EDT - 1 year ago

Nuwellis Announces Preliminary Results for Third Quarter of 2024

bazooka007
bazooka007 Feb. 4 at 8:26 AM
$NUWE hey NUWE show us a little good pr. Come on.
0 · Reply
rangervs
rangervs Feb. 4 at 12:39 AM
$BKYI nice movement still adding on the dips $NUWE same $GLSI
0 · Reply
Nuckle_Head
Nuckle_Head Feb. 3 at 2:53 PM
$NUWE looked like a double bottom on the chart. 📈 Cheers 🥂
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 3 at 1:44 PM
$NUWE RSI: 72.15, MACD: 0.4279 Vol: 0.85, MA20: 2.49, MA50: 2.34 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
nerowinger
nerowinger Feb. 2 at 9:15 PM
$NUWE split, dilution and repeat. Over years same story. Many patents and never cash…
1 · Reply
bazooka007
bazooka007 Feb. 2 at 7:35 PM
$NUWE finsih above 4 would be nice, finish above 4,15/4,20 would be super nice
0 · Reply
yaycapitalism
yaycapitalism Feb. 2 at 7:28 PM
$NUWE In.
0 · Reply
rangervs
rangervs Feb. 2 at 6:09 PM
$PBM c how this pans out power hour $NUWE still has some fuel ! $BKYI $1+ send it
0 · Reply
tonyzig
tonyzig Feb. 2 at 5:12 PM
$NUWE CTb shot to 560% this am and currently 428%. Looking squeezy…
0 · Reply
boredandstroked
boredandstroked Feb. 2 at 3:44 PM
$NUWE let's blow past 4.20 today.
0 · Reply
SwingTradesOnly
SwingTradesOnly Feb. 2 at 3:21 PM
$NUWE gap didn't close, you keep on hangin' in there don't you
1 · Reply
BioTuesdays
BioTuesdays Jan. 30 at 7:41 PM
$NUWE has announced the appointment of Carisa Schultz as chief financial officer (CFO), effective February 2, 2026 https://biotuesdays.com/2026/01/30/carisa-schultz-joins-nuwellis-as-cfo/
1 · Reply
rangervs
rangervs Jan. 30 at 5:37 PM
$BKYI road to +$1LAND $NUWE has potential
0 · Reply
Nuckle_Head
Nuckle_Head Jan. 30 at 4:25 PM
$NUWE chart is coiling:
0 · Reply
Investor6
Investor6 Jan. 30 at 4:19 PM
M&A news, $NUWE Nuwellis, Inc. today announced that it has entered into a Securities Purchase Agreement to acquire all of the issued and outstanding capital stock of Rendiatech Ltd., an Israeli-based medical technology company focused on automated kidney function monitoring. The transaction is expected to close following the satisfaction of customary closing conditions. BARK, BARK Inc., announced that a second go-private proposal by M. Lemonis has been released, at $1.10 per share in a all cash transaction. Current share price at $0.85.
0 · Reply
Nuckle_Head
Nuckle_Head Jan. 30 at 3:13 PM
$NUWE Holding. Cheers 🥂
0 · Reply
done84
done84 Jan. 30 at 2:25 PM
$NUWE Endless dilution. Scam. 🖕🖕
0 · Reply
DARKP00L
DARKP00L Jan. 30 at 2:12 PM
$NUWE 09:10 on Jan. 30 2026 Nuwellis shares are trading lower after the company announced a $5 million private placement. Also, the company announced it will acquire Rendiatech. #tradeideas
0 · Reply
OpenOutcrier
OpenOutcrier Jan. 30 at 1:28 PM
$NUWE (-16.5% pre) Nuwellis Stock Slips in After Hours On New Acquisition, $5M Placement Announcement https://ooc.bz/l/91381
0 · Reply
ustaad_30
ustaad_30 Jan. 30 at 1:05 PM
$NUWE
0 · Reply
ustaad_30
ustaad_30 Jan. 30 at 1:05 PM
$NUWE News is here guys📈
0 · Reply
jasonthack
jasonthack Jan. 30 at 8:23 AM
$NUWE 🧠 Bottom line • ❌ This placement does NOT free shorts • ❌ It does not immediately increase tradable float • ❌ Shorts still need open-market liquidity • ⚠️ Relief only comes after a resale S-1 is effective Translation in plain English: Shorts are still in the cage — they’re just hoping the door opens later.
0 · Reply